NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

Very interesting, considering that many of the faithful here have considered the 1st interim analysis halt to be a done deal for a long long time, yourself included. Now it is clearly time to move the carrot.

A very appropriate comparison to IMUC, in some ways this may be turning into a strikingly similar journey for L. Important to keep in mind that NWBO has a very good idea of what to expect from the phase III. Any notion that they are flying in the dark here is extremely naive.

Lastly, it also allows them to continue both trials until 2016, and pushes the make-it or break-it point out until then.

This might be your most salient point to date. Buying time is critical for NWBO. Direct needs as much time as possible to mature into something promising to keep the dreams alive.